Product Information
REMERON 30 MG TABLET is a brand product labeled by Organon LLC, priced at $6.6731 per EA under NDC 78206016101. Its NADAC has been published 81 times since Dec 18, 2024.
The High Outlier badge above means this manufacturer's average price in the MIRTAZAPINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Organon LLCNDC
78206016101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
MIRTAZAPINEApproval Type
New Drug (NDA)
FDA Application
NDA020415On Market Since
6/1/2021
Price Statistics
The NADAC for REMERON 30 MG TABLET has been published 81 times since Dec 18, 2024, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6731 per EA |
|---|---|
| All-time high | $6.6731 (Jul 1, 2026) |
| All-time low | $6.0731 (Dec 18, 2024) |
| 52-week high | $6.6731 |
| 52-week low | $6.3434 |
| Median price | $6.3770 |
| Average price | $6.4605 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 81 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the MIRTAZAPINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of REMERON 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REMERON 30 MG TABLET, manufactured by Organon LLC, is $6.6731 per EA (NDC 78206016101), effective Jul 1, 2026.
How has the price of REMERON 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for REMERON 30 MG TABLET has risen 9.9%. It has been tracked across 81 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for REMERON 30 MG TABLET?
Since Dec 18, 2024, the NADAC for REMERON 30 MG TABLET has ranged from a low of $6.0731 (Dec 18, 2024) to a high of $6.6731 (Jul 1, 2026), with a median of $6.3770 per EA.
Are there cheaper alternatives to REMERON 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of REMERON 30 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures REMERON 30 MG TABLET?
REMERON 30 MG TABLET (NDC 78206016101) is labeled by Organon LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification